May 01, 2023 | Breast Implants

2 Minute Read: 

A CLOSER LOOK AT THE FDA’S RECENT SAFETY COMMUNICATION

Hello everyone, I’m Dr. Frank Agullo, and today I’d like to talk about an important update from the U.S. Food and Drug Administration (FDA) regarding breast implants. The FDA has recently provided new information about reports of squamous cell carcinoma (SCC) and various lymphomas in the scar tissue (capsule) that forms around breast implants. It’s crucial for individuals with or considering breast implants to be aware of these findings and understand the potential risks.

WHAT THE FDA HAS FOUND

Based on a review of the literature and medical device reports, the FDA has identified 19 cases of SCC in the capsule around breast implants. Although the FDA still believes that occurrences of SCC in the capsule around breast implants may be rare, the cause, incidence, and risk factors remain unknown. Additionally, there have been reports of various lymphomas in the capsule, which are distinct from the previously described Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

RECOMMENDATIONS FOR INDIVIDUALS WITH OR CONSIDERING BREAST IMPLANTS

The FDA’s recommendations for individuals with or considering breast implants remain the same:

• UNDERSTAND THE RISKS AND BENEFITS: It’s essential to be well-informed about the potential risks and benefits of breast implants before deciding.
• CONTINUE ROUTINE MEDICAL CARE AND FOLLOW-UP: Regular check-ups and follow-up appointments with your health care provider are necessary to monitor the condition of your breast implants.
• BE AWARE OF REPORTED CASES: Stay informed about the reported cases of SCC and various lymphomas in the capsule around breast implants.
• MONITOR FOR CHANGES: Keep an eye on your breast implants for any changes, and promptly consult a surgeon or health care provider if you observe anything unusual.
• DO NOT REMOVE BREAST IMPLANTS DUE TO CONCERNS ONLY: It’s not recommended to remove breast implants solely due to concerns about developing SCC or various lymphomas if no symptoms are present.
• REPORT ANY PROBLEMS: If you experience any issues with your breast implants, report them to the FDA through the MedWatch program.

STAYING INFORMED AND VIGILANT

As a Board Certified Plastic Surgeon, I believe individuals must be well-informed about their choices and potential risks associated with breast implants. By staying updated on the latest information from the FDA and other reliable sources, you can make the best decisions for your health and well-being. If you have any concerns or questions, don’t hesitate to consult with a board-certified healthcare provider or surgeon. Together, we can work towards ensuring the safety and satisfaction of those who choose to undergo breast implant surgery. 

If you have questions or want to learn more about how it can help you, please call Southwest Plastic Surgery at (915) 590-7900 or fill out our contact form online.